The following are newly-released NCI research funding opportunities:
In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk
This funding opportunity will use the NIH investigator-initiated research project grants (R01) and Exploratory/Developmental (R21) award mechanism(s). For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2620. Inquiries: Dr. Cindy D. Davis - firstname.lastname@example.org.
Continued Development and Maintenance of Software
Correlative Studies with Specimens from Multi-Site Trials
For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.
The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. Newly released Roadmap funding opportunities are listed below. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.